THC Stock News & Analysis | Latest Updates

Tenet to Participate in the 2025 Wells Fargo Healthcare Conference

(NYSE:THC) DALLAS--(BUSINESS WIRE)--Tenet Healthcare Corporation (NYSE: THC) is scheduled to present at the 2025 Wells Fargo Healthcare Conference on Wednesday, September 3, 2025, beginning at 9:30 a.m. Eastern Time. A live webcast and audio archive of the event may be accessed through the investor relations section of Tenet’s website at www.tenethealth.com/investors. The replay will be available for 30 days. About Tenet Healthcare Tenet Healthcare Corporation (NYSE: THC) is a diversified healthcare servi

August 29, 2025Investor

THC News

Tenet to Participate in the 2025 Wells Fargo Healthcare Conference

Watching Tenet Healthcare Shares, Fuzzy Panda Issues Report On Stock

Morgan Stanley Maintains Overweight on Tenet Healthcare, Raises Price Target to $210

If You Invested $100 In This Stock 15 Years Ago, You Would Have This Much Today

12 Analysts Assess Tenet Healthcare: What You Need To Know

Barclays Maintains Overweight on Tenet Healthcare, Raises Price Target to $215

Wells Fargo Upgrades Tenet Healthcare to Overweight, Raises Price Target to $195

Demystifying Tenet Healthcare: Insights From 10 Analyst Reviews

Truist Securities Maintains Buy on Tenet Healthcare, Raises Price Target to $190

Goldman Sachs Maintains Neutral on Tenet Healthcare, Raises Price Target to $154

Morgan Stanley Maintains Overweight on Tenet Healthcare, Raises Price Target to $175

Barclays Maintains Overweight on Tenet Healthcare, Raises Price Target to $171

RBC Capital Maintains Outperform on Tenet Healthcare, Raises Price Target to $189

UBS Maintains Buy on Tenet Healthcare, Raises Price Target to $230

Tenet Healthcare Raises FY2025 GAAP EPS Guidance from $10.95-$12.47 to $11.37-$12.92 vs $11.99 Est

Tenet Healthcare Raises FY2025 Adj EPS Guidance from $11.74-$12.84 to $11.99-$13.12 vs $12.16 Est; Affirms FY2025 Sales Guidance of $20.60B-$21.00B vs $20.88B Est

A Peek at Tenet Healthcare's Future Earnings

Deep Dive Into Tenet Healthcare Stock: Analyst Perspectives (5 Ratings)

Baird Downgrades Tenet Healthcare to Neutral, Lowers Price Target to $137

Guggenheim Initiates Coverage On Tenet Healthcare with Buy Rating, Announces Price Target of $165

5 Analysts Assess Tenet Healthcare: What You Need To Know

Morgan Stanley Initiates Coverage On Tenet Healthcare with Overweight Rating, Announces Price Target of $165

Breaking Down Tenet Healthcare: 8 Analysts Share Their Views

Cantor Fitzgerald Reiterates Overweight on Tenet Healthcare, Maintains $177 Price Target

Barclays Maintains Overweight on Tenet Healthcare, Lowers Price Target to $161

Tenet Healthcare Forecasts FY2025 Net Operating Revenues Of $20.6B-$21B Versus Consensus Of $21.28B, With Adjusted EPS Of $11.74-$12.84 Versus Consensus Of $11.53

Tenet Healthcare Q4 2024 Adj EPS $3.44 Beats $2.97 Estimate, Sales $5.07B Miss $5.17B Estimate

(THC) - Analyzing Tenet Healthcare's Short Interest

Here's How Much $1000 Invested In Tenet Healthcare 5 Years Ago Would Be Worth Today

Peering Into Tenet Healthcare's Recent Short Interest

Wells Fargo Maintains Overweight on Tenet Healthcare, Raises Price Target to $205